Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 25;16(1):244.
doi: 10.1186/s12883-016-0754-5.

Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review

Affiliations

Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review

Zahra Goodarzi et al. BMC Neurol. .

Abstract

Background: Depression and anxiety remain under-diagnosed and under-treated in those with neurologic diseases such as dementia or Parkinson's Disease (PD). Our objectives were to first, to provide a synthesis of high quality guidelines available for the identification and management of depression or anxiety in those with dementia or PD. Second, to identify areas for improvement for future guidelines.

Methods: We searched MEDLINE, PsycINFO, and EMBASE (2009 to July 24, 2015), grey literature (83 sources; July 24-Sept 6, 2015), and bibliographies of included studies. Included studies were evaluated for quality by four independent reviewers the AGREE II tool. Guideline characteristics, statements and recommendations relevant to depression or anxiety for dementia and PD were then extracted. (PROSPERO CRD: 42016014584) RESULTS: 8121 citations were reviewed with 31 full text articles included for assessment with the AGREE II tool. 17 were of sufficient quality for inclusion. Mean overall quality scores were between 4.25 to 6.5. Domain scores were lowest in the areas of stakeholder involvement, applicability, and editorial independence. Recommendations for the screening and diagnosis of depression were found for PD and dementia. There was little evidence to guide diagnosis or management of anxiety. Non-pharmacologic therapies were recommended for dementia patients. Most advocated pharmacologic treatment for depression, for both PD and dementia, but did not specify an agent due to lack of evidence.

Conclusions: The available recent high quality guidelines outline several recommendations for the management of comorbid depression or anxiety in PD or dementia. However there remain significant gaps in the evidence.

Keywords: Anxiety; Dementia; Depression; Guidelines; Parkinson’s Disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA Flow Diagram

References

    1. Pachana NA, Egan SJ, Laidlaw K, Dissanayaka N, Byrne GJ, Brockman S, Marsh R, Starkstein S. Clinical issues in the treatment of anxiety and depression in older adults with Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 2013;28(14):1930–4. - PubMed
    1. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–189. doi: 10.1002/mds.21803. - DOI - PubMed
    1. Schrag A, Leentjens AF. Parkinson disease: scales to detect depression in Parkinson disease. Nat Rev Neurol. 2012;8(7):359–360. doi: 10.1038/nrneurol.2012.96. - DOI - PubMed
    1. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease. J Am Geriatr Soc. 2004;52(5):784–788. doi: 10.1111/j.1532-5415.2004.52219.x. - DOI - PubMed
    1. Kostic VS, Pekmezovic T, Tomic A, Jecmenica-Lukic M, Stojkovic T, Spica V, Svetel M, Stefanova E, Petrovic I, Dzoljic E. Suicide and suicidal ideation in Parkinson’s disease. J Neurol Sci. 2010;289(1-2):40–43. doi: 10.1016/j.jns.2009.08.016. - DOI - PubMed

Publication types